AIA
PFE icon

Aventus Investment Advisors’s Pfizer PFE Stock Holding History

Aventus Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$2.55K – 152
2025
Q3 		$2.55K Hold
100
– – ﹤0.01% 138
2025
Q2 		$2.42K Buy
+100
New +$2.33K ﹤0.01% 142

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aventus Investment Advisors's PFE Position: Q4 2025 in Review

Aventus Investment Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 100 shares — an estimated $2.55K sold.

Aventus Investment Advisors first reported a position in PFE in Q2 2025 and held it in 2 quarters. The position peaked at $2.55K in Q3 2025. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Aventus Investment Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Aventus Investment Advisors sold 100 Pfizer shares in Q4 2025, an estimated $2.55K.
  • Aventus Investment Advisors first reported a position in Pfizer in Q2 2025 and held it in 2 quarters.
  • Aventus Investment Advisors's Pfizer position peaked at $2.55K in Q3 2025.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Aventus Investment Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.